ArticleInvestigational new drugs2016

Molecular and cellular effects of a novel hydroxamate-based HDAC inhibitor - belinostat - in glioblastoma cell lines: a preliminary report.

Magdalena Kusaczuk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.